February 20, 2020         
7,000 Bacardi Employees Turn on Their ‘Out of Office’ to Visit Hundreds of Bars Across the Globe to Spark Conversati   •   All-New Honda LogR™ Datalogging App Helps Type R Drivers Improve Their Skills with Exclusive In-Depth Driving Data   •   Data Science Field Remains Unattractive to Many Female STEM Students   •   The Author Incubator Launches New Program for Spanish Speaking Entrepreneurs   •   U.S. Flunks Reproductive Health and Rights Report Card   •   iPhone 11 Pro doubles radiation exposure deemed safe for consumers, according to new test   •   Hemp Depot Redefines U.S. CBD Farming Economics With 70% Reduction in Feminized Seed Pricing   •   2021 Civic Type R Limited Edition: Ultimate Track-Focused Type R Coming to America   •   Comcast Celebrates the Year of the Rat With Continued Sponsorship of San Francisco’s Chinese New Year Festival & Parad   •   To Honor World Cancer Day, The WISDOM Study Seeks Support from Women to Modernize Breast Screening Guidelines   •   New ESA ‘Game Generation’ Campaign Shows Video Game Play Brings Benefits Beyond Fun   •   VHS Learning Opens 2020 Summer School Registration   •   The CBA National Apprenticeship Program Gets Approved by Department of Labor   •   2020 Honda Civic Type R Arriving Soon with Upgraded Performance, Honda Sensing® and new LogR™ Datalogging Smartphone A   •   R3 Stem Cell Heroes Program Performs Complimentary Regenerative Therapies on 70 Veterans in 2019   •   Fulton Mortgage Company Honored With First Annual Community Revitalization Award in Philadelphia   •   Lovers, Sub a Sandwich for a Ring This Leap Day and Quiznos May Cater Your Wedding – Assuming They Say “Yes”!   •   To Honor World Cancer Day, The WISDOM Study Seeks Support from Women to Modernize Breast Screening Guidelines   •   CER recommends approval for NGTL 2021 System Expansion Project   •   Cortica Opens Center For Autism Evaluations And Therapies In Westlake Village
Bookmark and Share

Blacks Benefiting From Targeted Cancer Therapy

 PHILDALPHIA — African-American patients with non-small cell lung cancer are just as likely to display an epidermal growth factor receptor (EGFR) mutation in tumors as Caucasians, which suggests they are as likely to benefit from targeted therapies such as erlotinib.

“This study has immediate implications for patient management. Patients with EGFR mutations have a much better prognosis and respond better to erlotinib than those who do not,” said Ramsi Haddad, Ph.D., director of the Laboratory of Translational Oncogenomics at the Barbara Ann Karmanos Cancer Institute, and assistant professor at Wayne State University School of Medicine.

Haddad’s study, which he presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development, also showed that African-Americans were more likely to have mutations on exon 19, rather than exon 21, which suggests they would be even more responsive to erlotinib.

Erlotinib, currently marketed as Tarceva by Genentech, has shown remarkable benefits in non-small cell lung cancer patients with EGFR mutations. Other therapies are in development and the genetic testing is clinically available.

Previous studies had suggested that African-Americans had lower rates of EGFR mutation, which researchers had offered as a possible explanation for their generally poorer prognosis.

However, Haddad’s study was larger than previous reports. His research team observed 149 patients with non-small cell lung cancer (NSCLC), including 80 Caucasians and 69 African-Americans.

Using state-of-the-art technology that allowed for simultaneous detection of hundreds of oncogene mutations in clinical samples, they identified EGFR mutations in 20 of these patients, including 12 Caucasians and eight African-Americans. The difference was not statistically significant.

Moreover, 100 percent of the EGFR mutations in African-Americans were in exon 19, compared with only two-thirds of the mutations found in Caucasian patients. 

“It is well-documented that the incidence of lung cancer is higher among African-Americans, particularly men, and that their survival is generally poorer compared to their white counterparts,” said Haddad. “Our data suggest that African-Americans with NSCLC harbor mutations in EGFR at rates similar to whites. Thus, African ancestry should not be a factor when deciding whether to test a tumor for these mutations, as doing so could widen the disparity seen in survival. Physicians treating these patients may want to consider this new information in their treatment decisions.” 

 


STORY TAGS: BLACK , AFRICAN AMERICAN , MINORITY , CIVIL RIGHTS , DISCRIMINATION , RACISM , NAACP , URBAN LEAGUE , RACIAL EQUALITY , BIAS , EQUALITY

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News